Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Circulating tumor DNA (ctDNA) has shown great promise as a minimally invasive liquid biopsy for personalized cancer diagnostics especially among metastatic patients. Here, we used a novel sensitive assay to detect clinically relevant mutations in ctDNA in blood plasma from metastatic non-small cell...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cells
Auteurs principaux: Belloum, Yassine, Janning, Melanie, Mohme, Malte, Simon, Ronald, Kropidlowski, Jolanthe, Sartori, Alexander, Irwin, Darryl, Westphal, Manfred, Lamszus, Katrin, Loges, Sonja, Riethdorf, Sabine, Pantel, Klaus, Wikman, Harriet
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690267/
https://ncbi.nlm.nih.gov/pubmed/33105541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112337
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires